Metraipolis › archive › dc_d8fa59fec21e

Comparative safety profiles of first-line immunotherapy regimens in advanced esophageal squamous cell carcinoma: a network meta-analysis focusing on toxicity… — Europe PMC PMID:41551148

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41551148
DOI
10.3389/fonc.2025.1700236
License (as archived)
solo-consultazione
Archived
2026-11-07T03:11:15.152Z
SHA-256 of the archived text
4aee28a7ead6916ee3587dfd6d2e5df2fbea26c5ee42ba7329c29904aa3850fa
Stable URL of this page
https://metraipolis.com/documento/dc_d8fa59fec21e

How to cite

Comparative safety profiles of first-line immunotherapy regimens in advanced esophageal squamous cell carcinoma: a network meta-analysis focusing on toxicity… — Europe PMC PMID:41551148 — Europe PMC (en), https://europepmc.org/article/MED/41551148 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8fa59fec21e (Metraipolis archive dc_d8fa59fec21e, sha256 4aee28a7ead6916ee3587dfd6d2e5df2fbea26c5ee42ba7329c29904aa3850fa)
BibTeX
@misc{dcd8fa59fec21e,
  title = {Comparative safety profiles of first-line immunotherapy regimens in advanced esophageal squamous cell carcinoma: a network meta-analysis focusing on toxicity… — Europe PMC PMID:41551148},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41551148},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8fa59fec21e; sha256 4aee28a7ead6916ee3587dfd6d2e5df2fbea26c5ee42ba7329c29904aa3850fa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41551148. Agents can read the archived copy with the MCP tool read_document.